影像组学与功能成像在肺癌中的应用:超越FDG PET/CT与肺活检的影像异质性价值
该回顾性研究纳入46例SUV<2.5且经CT引导下肺活检确诊的肺结节患者,评估CT纹理分析(CTTA)鉴别良恶性的能力。恶性结节显示较低峰度和较高偏度值,中滤波下峰度与偏度的AUC分别为0.654和0.642(P<0.001)。CTTA有望成为无葡萄糖代谢异常肺结节的无创影像生物标志物。
要点
- 对SUV<2.5的肺结节,CTTA的峰度和偏度有助于鉴别良恶性。
- 恶性结节峰度较低、偏度较高,中滤波下诊断效能有统计学意义。
- CTTA可作为PET/CT代谢阴性结节的无创补充评估工具。
关键影像表现/征象
- 恶性结节CTTA显示较低的峰度值(所有P≤0.0013)。
- 恶性结节CTTA显示较高的偏度值(所有滤波TA P<0.024)。
诊断标准与关键数值
- 峰度与偏度在中滤波下ROC曲线下面积分别为0.654和0.642(P<0.001)。
临床应用与阅片要点
- 对FDG PET/CT SUV<2.5的肺结节,可尝试CTTA分析峰度和偏度辅助鉴别良恶性。
- CTTA可作为减少不必要活检的无创影像生物标志物。
局限性
- 回顾性单中心设计,样本量仅46例,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET/CT) has a central role in the lung nodules' characterization even if, with SUV < 2.5, percutaneous CT-guided Lung Biopsy (CTLB) is needed to assess nodule nature. In that scenario, CT Texture Analysis (CTTA) could be a non-invasive imaging biomarker. Our purpose is to test CTTA ability in differentiating malignant from benign nodules.
METHOD: Patients that underwent FDG PET/CT followed by CTLB between January 2013 and December 2018 were retrospectively enrolled. Were included patients with lung nodule SUV < 2.5 and histological diagnosis.
EXCLUSION CRITERIA: nodules SUV > 2.5, patients who refused CTLB or received oncological treatment before CTLB, indeterminate pathology report, CT motion artifacts. Two radiologists in consensus performed CTTA, drawing a volumetric Region of Interest of nodule with a dedicated first order TA software with and without spatial scaling filters, on preliminary CT performed for CTLB. Statistics included a comparison between malignant and benign neoplasms distribution (2-tailed T-test or Mann-Whitney test according to normal/non-normal data distribution), P-values < 0.05 were considered statistically significant. CTTA accuracy was tested with Receiver Operating Characteristics (ROC) curve.
RESULTS: Form an initial population of 1178, 46 patients encountered inclusion criteria. Pathologist reported 27/46 (59%) malignant and 19/46 (41%) benign nodules. In malignant lesions CTTA showed lower Kurtosis' and higher Skewness' values (all P ≤ 0.0013 and all filtered TA P < 0.024, respectively). ROC curve showed significant Area Under the Curve for Kurtosis and Skewness (0.654 and 0.642, P < 0.001) at medium filtration.
CONCLUSIONS: CTTA is a promising radiological tool to characterize benign and malignant lung nodules, even in those cases without an altered glucose metabolism.
引用
- Caruso D, Zerunian M, Daffina J, et al. Radiomics and functional imaging in lung cancer: the importance of radiological heterogeneity beyond FDG PET/CT and lung biopsy. Eur J Radiol. 2021. PMID: 34339955. doi:10.1016/j.ejrad.2021.109874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。